Psychiatry and Neurology, Neurology · Tarentum, PA
NPI
1649303108
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
12
Medicare group memberships
Hospitals
5
Hospital affiliations
215 E 1st Ave
Tarentum, PA, 15084
Phone (724) 749-4118
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,109 services
Medicare patients, 2024
615
Average age 75
Drug cost, 2024
$2.0M
2,621 prescriptions
Company payments, 2025
$437
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew P Kozminski was code G0408 (follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth), 482 times for 281 patients. In total Matthew P Kozminski billed 1,109 services in 32 codes, and Medicare paid $88K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Facility | 482 | 281 | $78.95 | $38K |
| 99214 Office E&M - Established | Office | 106 | 80 | $81.01 | $8,587 |
| 99232 Hospital E&M - Subsequent | Facility | 89 | 52 | $53.85 | $4,793 |
| 99215 Office E&M - Established | Office | 73 | 54 | $121.15 | $8,844 |
| 99223 Hospital E&M - Initial | Facility | 47 | 46 | $128.28 | $6,029 |
| 99233 Hospital E&M - Subsequent | Facility | 42 | 34 | $83.24 | $3,496 |
| 99232 Hospital E&M - Subsequent | Office | 40 | 25 | $61.31 | $2,452 |
| 99213 Office E&M - Established | Office | 28 | 26 | $48.48 | $1,357 |
| 95819 Neurologic | Facility | 26 | 26 | $42.45 | $1,104 |
| G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Facility | 23 | 23 | $98.93 | $2,275 |
| G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 23 | 20 | $81.67 | $1,878 |
| 95816 Neurologic | Facility | 19 | 16 | $42.31 | $804 |
| 99205 Office E&M - New | Office | 18 | 18 | $145.66 | $2,622 |
| 99222 Hospital E&M - Initial | Facility | 12 | 11 | $96.43 | $1,157 |
| G0425 Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 11 | 11 | $70.58 | $776 |
By year: 2022 $33K for 405 services; 2023 $63K for 725 services; 2024 $88K for 1,109 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew P Kozminski prescribed most often to Medicare patients was Levetiracetam, with 156 prescriptions and refills. In total Matthew P Kozminski wrote 2,621 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 156 | 185 | 39 | $4,442 |
| Gabapentin Generic | 145 | 177 | 41 | $2,199 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 141 | 188 | 35 | $4,799 |
| Topiramate Generic | 104 | 129 | 29 | $1,294 |
| Donepezil Hcl Generic | 99 | 131 | 29 | $810 |
| Lamotrigine Generic | 67 | 81 | 20 | $919 |
| Aimovig Autoinjector Erenumab-Aooe | 66 | 66 | 13 | $48K |
| Baclofen Generic | 63 | 93 | 22 | $1,865 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 55 | 84 | 15 | $737 |
| Memantine Hcl Generic | 54 | 78 | 17 | $4,578 |
| Pregabalin Generic | 49 | 51 | 12 | $699 |
| Botox Onabotulinumtoxina | 45 | 127 | 17 | $79K |
| Divalproex Sodium Generic | 40 | 42 | Under 11 | $1,226 |
| Ropinirole Hcl Generic | 39 | 47 | Under 11 | $379 |
| Lacosamide Generic | 39 | 47 | 12 | $3,957 |
Brand drugs: 575 claims; generic drugs: 2,015 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew P Kozminski $437 ($437 in general payments such as food, travel and fees) from 8 companies. The largest payer was Genzyme Corporation with $299.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.